SOPHiA GENETICS SA is a cloud-native software technology company that provides data analytics and insights solutions for healthcare organizations. The company's core offering is the SOPHiA DDM (Digital Disease Management) platform, a cloud-based software system designed to analyze multimodal diagnostic data sets and generate clinical insights. The platform processes data from various diagnostic modalities and supports decision-making across clinical and research workflows.
The company serves hospitals, diagnostic laboratories, and biopharmaceutical organizations through a combination of direct sales efforts and partnerships with distributors and industry collaborators. Its customer base is distributed across multiple geographies, including Switzerland, France, Italy, and other European countries, as well as North America, the United States, Latin America, and the Asia-Pacific region.
Founded in 2011 and headquartered in Rolle, Switzerland, SOPHiA GENETICS SA operates with approximately 423 full-time employees. The company is listed on Nasdaq and operates primarily within the health information services sector, providing computer processing and data preparation services to the healthcare industry.
No 10-K filings found.